js005
mAbexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Dec 10, 2021 (NCT05212051)
Timeline
Indications
Mechanism of action
- Interleukin 17AANTAGONIST
IL17A antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06732973 | Phase 1 | Dec 20, 2024 | Shanghai Junshi Bioscience Co.,Ltd., Sponsor GmbH |
| NCT06250062 | Phase 2 | Jan 12, 2024 | Second Military Medical University, Shanghai Junshi Bioscience Co.,Ltd., Sponsor GmbH |
| NCT05242588 | Phase 2 | Jan 26, 2022 | Shanghai Junshi Bioscience Co.,Ltd., Sponsor GmbH |
| NCT05212051 | Phase 2 | Dec 10, 2021 | Shanghai Junshi Bioscience Co.,Ltd., Sponsor GmbH |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Junshi Bioscience Co.,Ltd. | For profit | 4 | 4 | 2 | 2021 |
| Sponsor GmbH | Academic/Hospital | 4 | 0 | 2 | 2021 |
| Second Military Medical University | Government | 1 | 0 | 1 | 2024 |
3 organizations
Page 1 / 1